Catalyst Wire Dossier Catalyst Wire Dossier

Guilu Erxian Oral Liquid

· DongE E Jiao Corporation Limited
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Guilu Erxian Oral Liquid, covering 2025-12-08 to 2025-12-08. Get the full timeline:

Most recent: Clinical Trial Update: Effectiveness and Safety of Guilu Erxian Oral Liquid in the Treatment of Oligozoospermia and Asthenospermia With Syndrome of Shen (Kidney) Essence Deficiency [Phase 4]

See pricing